Company Profiles

driven by the PitchBook Platform

Seldar Pharma

Seldar Pharma
2012 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$13M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of a drug for the treatment of irritable bowel syndrome with diarrhea. The company is developing ASP7147 which is in phase I Multiple Ascending Dose study.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Primary Office
520 US Highway 22
Suite 201
Bridgewater, NJ 08807
United States

+1 (908) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Seldar Pharma’s full profile, request a free trial.

Seldar Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 06-Dec-2013 $13M 0000 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Seldar Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
To view this company’s complete Cap Table, request access »

Seldar Pharma Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Astellas Venture Management Corporate Venture Capital Minority 000 0000 000000 0
InterWest Partners Venture Capital Minority 000 0000 000000 0
Sutter Hill Ventures Venture Capital Minority 000 0000 000000 0
Questions or concerns about this profile? Reach out to website-support@pitchbook.com